ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Dose Volume Analysis of Radiotherapy for Inoperable Patients with Stage I-II Endometrial Carcinoma

https://repo.qst.go.jp/records/46263
https://repo.qst.go.jp/records/46263
73f47649-67d9-47e2-b735-2d1a6979c05f
Item type 学術雑誌論文 / Journal Article(1)
公開日 2012-02-06
タイトル
タイトル Dose Volume Analysis of Radiotherapy for Inoperable Patients with Stage I-II Endometrial Carcinoma
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Ohkubo, Yu

× Ohkubo, Yu

WEKO 460749

Ohkubo, Yu

Search repository
Kato, Shingo

× Kato, Shingo

WEKO 460750

Kato, Shingo

Search repository
Kiyohara, Hiroki

× Kiyohara, Hiroki

WEKO 460751

Kiyohara, Hiroki

Search repository
Tsuruoka, Ichirou

× Tsuruoka, Ichirou

WEKO 460752

Tsuruoka, Ichirou

Search repository
Tamaki, Tomoaki

× Tamaki, Tomoaki

WEKO 460753

Tamaki, Tomoaki

Search repository
Noda, Shinei

× Noda, Shinei

WEKO 460754

Noda, Shinei

Search repository
Ohno, Tatsuya

× Ohno, Tatsuya

WEKO 460755

Ohno, Tatsuya

Search repository
Nakano, Takashi

× Nakano, Takashi

WEKO 460756

Nakano, Takashi

Search repository
大久保 悠

× 大久保 悠

WEKO 460757

en 大久保 悠

Search repository
加藤 眞吾

× 加藤 眞吾

WEKO 460758

en 加藤 眞吾

Search repository
鶴岡 伊知郎

× 鶴岡 伊知郎

WEKO 460759

en 鶴岡 伊知郎

Search repository
田巻 倫明

× 田巻 倫明

WEKO 460760

en 田巻 倫明

Search repository
野田 真永

× 野田 真永

WEKO 460761

en 野田 真永

Search repository
大野 達也

× 大野 達也

WEKO 460762

en 大野 達也

Search repository
抄録
内容記述タイプ Abstract
内容記述 This study aims to assess the efficacy and toxicity of definitive radiotherapy for early-stage endometrial carcinoma. The correlation between CT-based dosimetric parameters and clinical outcomes is also evaluated. Between 2002 and 2006, 10 medically inoperable patients with T1-2 endometrial carcinoma were treated with radiotherapy alone. A combination of external beam radiotherapy (EBRT) and high-dose-rate intracavitary brachytherapy (HDR-ICBT) was used for 9 patients, and one was treated with HDR-ICBT alone. Dose prescription of HDR-ICBT was determined in reference to CT images at brachytherapy, and a total dose of 22–24 Gy in 4 fractions was delivered to the outer perimeter of the uterine corpus. Dose-volume parameters of the gross tumor volume (GTV), clinical target volume (CTV), and organs at risk were assessed retrospectively using the dose-volume histograms derived from the CT image-based treatment planning system. After a median follow-up of 55 months, 9 patients were alive without evidence of recurrence. One patient died from liver cirrhosis 17 months after radiotherapy. Severe acute and late toxicities were not observed in any of the patients. Average minimum dose to 90% of GTV and CTV (D90) was 88.0 and 45.9 GyEQD2, respectively. The minimum dose delivered to 2 cc of the most irradiated volumes of the rectum and sigmoid colon (D2cc) was 78.9 and 65.9 GyEQD2, respectively. These patients developed Grade 1 late complications. In this study, stage I–II endometrial carcinoma was well-controlled locally with minimum late toxicity by radiotherapy alone with HDR-ICBT. 3D image-based brachytherapy may potentially deliver a sufficiently high dose to the whole tumor without significant increase in dose to surrounding normal tissues.
書誌情報 Journal of Radiation Research

巻 52, 号 5, p. 666-673, 発行日 2011-08
ISSN
収録物識別子タイプ ISSN
収録物識別子 0449-3060
DOI
識別子タイプ DOI
関連識別子 10.1269/jrr.11024
関連サイト
識別子タイプ URI
関連識別子 http://www.jstage.jst.go.jp/browse/jrr/52/5/_contents/-char/ja/
関連名称 http://www.jstage.jst.go.jp/browse/jrr/52/5/_contents/-char/ja/
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:53:56.972280
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3